Stocks to Buy for Short Term: Axis Securities picks 2 largecaps and 3 midcaps for up to 11% gain in 15 days; check target price
Stock to Buy for 15 Days: Brokerage Axis Securities has 5 selected stocks from the defence, pharma and tech sectors which may rise up to 11 per cent in the next 15 days. As leading indices – BSE Sensex and Nifty 50 – recovered to close in positive territory today (May 21, 2025), can these stocks also get momentum? Know their target prices, stop losses and entry point.
)
06:26 PM IST
Stock to Buy for 15 Days: Leading indices – BSE Sensex and Nifty 50 – recovered on Wednesday (May 21, 2025) after a lacklustre show in 3 consecutive trading sessions. Amid such market situations, brokerage Axis Securities has chosen 5 stocks for up to 15 days for a potential upside of 11 per cent. The stocks are from the defence, pharma and digital technology sectors. Check their target prices.
1. Data Patterns (defence sector)
Current Price: Rs 2,744.25 (BSE close on May 21)
Entry Price Range: Rs 2,700 – Rs 2,727
Stop Loss: Rs 2,670
Target: Rs 2,945
Reason for selection- The brokerage says that the midcap defence sector firm has a strong order book in the defence segment and the government's PLI policy is driving the stock growth. The brokerage says a returns of up to 8 per cent is possible.
2. Shilpa Medicare (pharma sector)
Current Price: Rs 702.80
Entry Price Range: Rs 714 – Rs 722
Stop Loss: Rs 707
Target: Rs 767
Reason for selection- The brokerage says that the midcap company’s hold in the API segment and new launches are expected to help it reach the target.
3. Affle India (digital ad-tech sector)
Current Price: Rs 1,701.80
Entry Price Range: Rs 1,690 – Rs 1,707
Stop Loss: Rs 1,665
Target: Rs 1,833
Reason for selection- Axis Securities says that the largecap stock is seeing an upside of more than 8 per cent due to growth in the digital advertising market.
4. Krishna Institute of Medical Sciences (healthcare education)
Current Price: Rs 662.95
Entry Price Range: Rs 651 – Rs 658
Stop Loss: Rs 642
Target: Rs 706
Reason for selection- Axis Securities says that due to the dual benefits of education and healthcare, the largecap stock is becoming the choice of investors.
Natco Pharma (pharma sector)
Current price: Rs 875.85
Entry price range: Rs 871–Rs 879
Stop loss: Rs 848
Target: Rs 972
Reason for selection- The brokerage says that the midcap stock can give a return of up to 11 per cent due to the company’s presence in branded generics and the US market.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
)
)
)
)
)
)
)
)
)
)
)
5 Stocks to buy for long term: Analysts recommend largecap, midcap stocks; L&T on the list
Stock market update: Sensex down 587 points, Nifty drops 177 amid rising Middle East tensions; gold hits new high of Rs. 1 lakh
Rakesh Bansal bullish on 2 largecaps for 4-5% gains in short term: Check stop losses, targets
Stocks to Track on June 12: HCLTech, Canara Bank, MCX, Minda Corp, OMCs in spotlight
First Trade: Indices open mildly higher; Nifty at 25,123
